Multidrug-resistant Acinetobacter baumannii

Aharon Abbo, Shiri Navon-Venezia, Orly Hammer-Muntz, Tami Krichali, Yardena Siegman-Igra, Yehuda Carmeli

Research output: Contribution to journalArticlepeer-review

223 Scopus citations


To understand the epidemiology of multidrug-resistant (MDR) Acinetobacter baumannii and define individual risk factors for multidrug resistance, we used epidemiologic methods, performed organism typing by pulsed-field gel electrophoresis (PFGE), and conducted a matched case-control retrospective study. We investigated 118 patients, on 27 wards in Israel, in whom MDR A. baumannii was isolated from clinical cultures. Each case-patient had a control without MDR A. baumannii and was matched for hospital length of stay, ward, and calendar time. The epidemiologic investigation found small clusters of up to 6 patients each with no common identified source. Ten different PFGE clones were found, of which 2 dominated. The PFGE pattern differed within temporospatial clusters, and antimicrobial drug susceptibility patterns varied within and between clones. Multivariate analysis identified the following significant risk factors: male sex, cardiovascular disease, having undergone mechanical ventilation, and having been treated with antimicrobial drugs (particularly metronidazole). Penicillins were protective. The complex epidemiology may explain why the emergence of MDR A. baumannii is difficult to control.

Original languageEnglish
Pages (from-to)22-29
Number of pages8
JournalEmerging Infectious Diseases
Issue number1
StatePublished - Jan 2005
Externally publishedYes


Dive into the research topics of 'Multidrug-resistant Acinetobacter baumannii'. Together they form a unique fingerprint.

Cite this